Mutations in the KIT extracellular domain have been reported not only in mast cellmalignances, but also in various other cancers such as acute myeloid leukemia (AML) andGIST16, 17, 18, 19, 20, 21. This evidence concerns the gene KIT and acute myeloid leukemia.